The New Revolutionary: Ovid's Levin On Pioneering In Neurology

 
• By Lubna Ahmed
  
Emerging Company Profile Regular column feature image Version 2
Ovid Therapeutics' CEO Jeremy Levin talks to Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business